REAL WORLD FACTOR DISPENSATION AND EXPENDITURES IN US PATIENTS WITH HEMOPHILIA B: STANDARD HALF-LIFE VS. EXTENDED HALF-LIFE FACTOR IX REPLACEMENT PRODUCTS

被引：0

作者：

Chhabra, A. ^{[1
]}

Spurden, D. ^{[2
]}

Tortella, B. J. ^{[3
]}

Fogarty, P. F. ^{[3
]}

Pleil, A. ^{[4
]}

Rubinstein, E. ^{[1
]}

Alvir, J. ^{[1
]}

机构：

[1] Pfizer Inc, New York, NY USA

[2] Pfizer Ltd, Surrey, England

[3] Pfizer Inc, Collegeville, PA USA

[4] Pfizer Inc, San Diego, CA USA

来源：

VALUE IN HEALTH | 2018年 / 21卷

关键词：

D O I：

10.1016/j.jval.2018.07.849

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSY35

引用

页码：S111 / S111

页数：1

共 50 条

[1] FACTOR DISPENSATION AND EXPENDITURES IN HEMOPHILIA B PATIENTS SWITCHING FROM STANDARD HALF-LIFE TO EXTENDED HALF-LIFE RECOMBINANT FACTOR IX REPLACEMENT PRODUCTS: REAL-WORLD ANALYSIS IN JAPAN
Karumori, T.
Chhabra, A.
Alvir, J.
Fogarty, P. F.
Spurden, D.
Tortella, B. J.
Rubinstein, E.
Pleil, A.
VALUE IN HEALTH, 2018, 21 : S111 - S111
[2] REAL-WORLD DATA ANALYSIS OF US CLAIMS DATA ON COAGULATION FACTOR IX DISPENSATION AND EXPENDITURES IN PATIENTS WITH SEVERE HEMOPHILIA B: STANDARD HALF-LIFE VS. EXTENDED HALF-LIFE PRODUCTS
Chhabra, A.
Fogarty, P. F.
Tortella, B. J.
Rubinstein, E.
Spurden, D.
Alvir, J.
VALUE IN HEALTH, 2018, 21 : S447 - S447
[3] REAL WORLD DATA ANALYSIS OF US CLAIMS DATABASE ON COAGULATION FACTOR IX EXPENDITURES IN PATIENTS WITH HEMOPHILIA B: STANDARD HALF-LIFE VS. EXTENDED HALF-LIFE PRODUCTS
Spurden, D.
Chhabra, A.
Tortella, B. J.
Fogarty, P. F.
Rubinstein, E.
Pleil, A.
Alvir, J.
VALUE IN HEALTH, 2018, 21 : S262 - S262
[4] Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US
Chhabra, Amit
Alvir, Jose
Spurden, Dean
Fogarty, Patrick F.
Tortella, Bartholomew
McDonald, Margaret
Pleil, Andreas M.
BLOOD, 2017, 130
[5] Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products
Tortella, Bartholomew J.
Alvir, Jose
McDonald, Margaret
Spurden, Dean
Fogarty, Patrick F.
Chhabra, Amit
Pleil, Andreas M.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 643 - 653
[6] Real World Analysis of Coagulation Factor IX Utilization and Costs in Hemophilia B Patients Switching From Standard Half-Life To Extended Half-Life Products
Tortella, B. J.
Fogarty, P. F.
Alvir, J.
Mcdonald, M.
Spurden, D.
Pleil, A. M.
HAEMOPHILIA, 2017, 23 : 41 - 42
[7] Real-World expenditures associated with Prophylactic Factor IX replacement in Severe Hemophilia B patients in the US: A comparison between standard and extended half-life products
Fogarty, Patrick
Alvir, Jose
Spurden, Dean
Tortella, Bartholomew
McDonald, Margaret
Pleil, Andreas
Chhabra, Amit
HAEMOPHILIA, 2018, 24 : 26 - 26
[8] Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products
Tortella, Bartholomew J.
Fogarty, Patrick F.
Alvir, Jose
McDonald, Margaret
Spurden, Dean
Pleil, Andreas M.
BLOOD, 2016, 128 (22)
[9] Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B
Chhabra, Amit
Spurden, Dean
Fogarty, Patrick F.
Tortella, Bartholomew J.
Rubinstein, Emily
Harris, Simon
Pleil, Andreas M.
Mellor, Jennifer
de Courcy, Jonathan
Alvir, Jose
BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (03) : 186 - 192
[10] REAL-WORLD SPECIALTY PHARMACY DISPENSATION AND EXPENDITURES ASSOCIATED WITH STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS AMONG HEMOPHILIA B PATIENTS RECEIVING ON-DEMAND REGIMENS
Fogarty, Patrick F.
Alvir, Jose
Chhabra, Amit
McDonald, Margaret
Tortella, Bartholomew J.
Pleil, Andreas M.
Spurden, Dean
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E19 - E20

← 1 2 3 4 5 →